Why Needle-Free Diabetes Care Is Gaining Traction | Market Size & Forecast According to a newly published market research report by 24LifeSciences, global needle-free diabetes care market was valued at USD 5.65 billion in 2026 and is projected to reach USD 11.52 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.8% during the forecast period. Needle-free diabetes care represents a revolutionary segment of medical technology designed to manage diabetes without traditional hypodermic needles, addressing critical challenges like needle phobia, pain, and infection risk associated with daily injections. These advanced solutions encompass insulin patches, jet injectors, insulin pumps, inhalable insulin systems, and continuous glucose monitoring (CGM) devices that eliminate finger-prick blood sampling. This paradigm shift enhances patient compliance and quality of life, particularly for pediatric and geriatric populations who struggle with conventional injection methods. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8939/needle-free-diabetes-care-market